PEPTIDES BRANDS
Launch a peptide brand on Tessic Health
Tessic Health runs the clinic behind a peptide brand. Licensed providers evaluate and prescribe in all 50 states, licensed pharmacies make and ship each prescription cold at wholesale cost, and patients buy through a storefront with your name on it. The formulary is limited to peptides with a lawful route to a patient, which is what keeps a peptide brand able to advertise and take card payments.
50
States with licensed providers
0%
Markup on compounded fills
0
Research-grade products shipped
$25
Flat per completed consult
CLINICAL
What your peptide patients get
Peptide programs are built around a stated goal, a provider evaluation and a review before every new cycle, run by providers credentialed under your brand.
01
Intake built around a goal
Patients state a goal, such as body composition, recovery, sleep or healthy aging, along with their health history and medications. The provider weighs each peptide against that goal.
02
Lab work where it matters
Growth hormone-releasing peptides start with an IGF-1 level and recheck it during treatment. Labs run through contracted networks and post to the chart.
03
Safety screening
Active cancer and pregnancy rule out growth hormone-releasing peptides. Providers screen for both, and for interacting medications, before prescribing.
04
Injection instructions
Most peptides are injected under the skin at home. Patients receive instructions on mixing, storage, dosing and sharps disposal with their first shipment.
05
A review before each cycle
Many peptide protocols run in cycles. Providers review progress and side effects before each new cycle is filled.
MEDICATIONS & PROTOCOLS
What your providers can prescribe
Peptide programs on Tessic start from products that are FDA-approved or that a licensed pharmacy can lawfully compound. Providers choose among them for each patient after an evaluation. NAD+ and glutathione depend on FDA's interim policy for substances still under review, so their status can change.
| Medication | Form | Used for | How it is filled |
|---|---|---|---|
| Sermorelin | Nightly injection | Growth hormone support in adults, off-label | 503A pharmacy, shipped cold |
| Tesamorelin (Egrifta WR) | Daily injection | FDA-approved for excess belly fat in HIV lipodystrophy; off-label otherwise | Specialty pharmacy |
| NAD+ | Injection or nasal spray | Energy and healthy-aging programs, off-label | 503A pharmacy |
| Glutathione | Injection | Antioxidant programs, off-label | 503A pharmacy |
| Bremelanotide (Vyleesi) | Injection, as needed | FDA-approved for low sexual desire in premenopausal women | Specialty pharmacy |
| Semaglutide, tirzepatide | Weekly injection | Weight management, on the weight loss protocol | See the weight loss page |
Left off the list on purpose
Each of these would put the brand's ad accounts, payment accounts or medical licenses at risk.
Peptides FDA has flagged as unsafe to compound
FDA's Category 2 list names bulk substances it considers too risky for pharmacies to compound. Anything on that list stays off the formulary for as long as it stays there.
Peptides with no lawful way to be compounded
A pharmacy may only compound a substance that is FDA-approved, part of an approved drug, covered by a USP monograph or on a list FDA allows. Several peptides sold widely online pass none of those tests, and they are not offered.
Research-grade peptides
Products labeled "for research use only" or "not for human consumption" are never prescribed or shipped. Every fill is dispensed by a licensed pharmacy on a prescription for one named patient.
Every prescription is the treating provider's decision after an individual evaluation, and a listing here does not mean every patient qualifies. Off-label means FDA has not approved the drug for that use; providers may still prescribe it when clinically appropriate.
PHARMACY
How the medicine gets to patients
Most peptides are compounded, so a peptide brand is only as sound as the pharmacies behind it.
01
503A pharmacies, one patient at a time
State-licensed 503A pharmacies compound each peptide against a prescription for one named patient, and they may only use substances that are eligible for compounding.
02
503B facilities where eligible
Where a product is eligible for 503B production, FDA-registered outsourcing facilities make it in batches under current good manufacturing practice, with potency and sterility testing.
03
Branded peptides at the pharmacy's price
FDA-approved peptides such as tesamorelin and bremelanotide fill through specialty pharmacies. The brand pays what the pharmacy charges.
04
Cold shipping and short shelf lives
Peptides ship refrigerated and carry short beyond-use dates once mixed. Fill sizes are set so patients finish each vial before it expires.
0%
Markup on every fill, on every plan
The brand is billed the pharmacy's wholesale invoice. Tessic adds nothing to the medication and takes no share of what the brand charges patients.
COMPLIANCE & ADVERTISING
The rules for selling peptides
What regulators and ad platforms check before a peptide brand can sell and advertise.
What regulators check
01
Federal lists decide what can be sold
Whether a peptide can be compounded is a federal question. FDA reclassified a group of peptides in 2026 and more decisions are pending, so the formulary changes only when FDA's lists do.
02
Most peptide use is off-label
Providers may prescribe off-label after an evaluation. Marketing that promises results for an off-label use is a health claim, and the FTC expects scientific evidence behind it.
03
Research chemicals sold for people are drugs
Selling "research use only" peptides to consumers has drawn FDA warning letters. A peptide brand on Tessic ships only pharmacy-dispensed prescriptions.
04
Athletes and banned substances
Growth hormone-releasing peptides such as sermorelin and tesamorelin are on the World Anti-Doping Agency's prohibited list. Brands that market to athletes should say so plainly.
What ad platforms check
01
Ad platforms treat peptides as drugs
Google and Meta handle injectable peptides as prescription drugs. Ads need LegitScript certification, and platforms reject ads for substances they consider unapproved.
02
No anti-aging promises
Copy such as "reverse aging", "boost growth hormone" or "build muscle fast" draws ad rejections and FTC attention. Ads can describe the program and the provider evaluation.
03
Careful with physique photos
Meta restricts before-and-after images and pictures of unlikely results, which covers most body-composition marketing.
Rules for every category
LegitScript certification
Google, Meta and the major card processors check for LegitScript certification before a telehealth brand can advertise prescription treatment or take card payments. Tessic prepares and files the application as part of setup.
Subscription billing
The Restore Online Shoppers' Confidence Act requires the recurring price and terms to be clear before checkout, the buyer's express consent to the charge, and a simple way to cancel.
Health data and ad pixels
Tracking pixels that pass health information to ad platforms have drawn FTC and HHS enforcement. Conversion tracking on a clinic site has to keep intake answers and diagnoses out of what reaches Meta and Google.
Proof behind every claim
The FTC expects competent and reliable scientific evidence behind health claims, and testimonials have to reflect what typical patients experience.
Rules checked September 2026. A planning summary, not legal advice. Rules change, LegitScript sets its own review schedule, and certification is never guaranteed. The brand's own counsel should review its marketing before launch.
LAUNCH TIMELINE
How fast your clinic opens
Peptide brands usually take first patients within a week. Choosing the product list takes the most care, because every peptide has to pass the compounding check first.
Day 0
Discovery call
The brand names the peptides it wants to offer. Tessic checks each one for a lawful pharmacy route and flags any that fail.
Days 1-3
Clinic build
Providers are credentialed under the brand, goal-based intakes and lab orders are loaded, and the storefront goes up. Tessic prepares the LegitScript application.
Days 3-5
Pharmacy and test orders
Compounding pharmacies are connected, and test orders run from intake to a cold delivery with injection instructions.
Days 5-7
First patients
The clinic opens to patients from the brand's own audience while ad accounts wait on certification.
After certification
Paid ads
Once LegitScript certification clears, campaigns can run within each platform's prescription drug policy.
Timelines assume the brand's name, domain and pricing are ready at the discovery call.
UNIT ECONOMICS
What one patient is worth
A sample model for one patient on a monthly sermorelin program at $199 a month. The brand sets the price, medication passes through at wholesale, and Tessic's only per-patient fee is $25 per completed consult.
- Program price, set by the brand
- $199.00
- Sermorelin, 30-day supply, at wholesale (assumed)
- −$85.00
- Provider consults: 4 a year at $25, spread monthly
- −$8.33
- Cold-chain shipping (assumed)
- −$15.00
- IGF-1 labs, twice a year (assumed)
- −$10.00
- Card processing (3% of price, assumed)
- −$5.97
- Contribution per patient, monthly38% of price, before marketing
- $74.70
14
Patients to cover the Launch plan's $1,000 monthly fee
27
Patients to cover the Grow plan's $2,000 monthly fee
108
Patient-months to earn back the $8,000 Launch setup fee
$8.33
Tessic's monthly fee on this patient, against $45.40 on a 30% markup and 10% revenue-share model
Illustrative only, not a quote or a forecast. The brand sets its own prices; lines marked assumed are sample costs, and the real pharmacy invoice passes through at 0% markup. Contribution is before marketing, the monthly platform fee and taxes. The comparison model applies a 30% medication markup and a 10% revenue share, within the range commonly seen in white-label agreements.
COMMON QUESTIONS
Questions about launching a peptide brand
Not yet. FDA took BPC-157 off its Category 2 safety-risk list in 2026, and an FDA advisory committee has since voted to add it to the list of substances 503A pharmacies may compound, but as of September 2026 no final listing has followed. The formulary adds a peptide once FDA's lists allow licensed pharmacies to compound it.
Ad platforms and card processors review what a brand sells. A list limited to lawful, pharmacy-dispensed peptides is what gets a peptide brand through LegitScript review and keeps its payment accounts open.
The treating provider, after reviewing the patient's goal, history and labs. The brand chooses which programs to offer and how to price them; clinical decisions stay with licensed clinicians under the friendly-PC structure.
Refrigerated, from pharmacies licensed in the patient's state, with instructions for mixing, storage and sharps disposal. Fill sizes follow each product's beyond-use date.
The plan's flat monthly fee, $25 per completed consult, and nothing on the medication. Compounded fills pass through at the pharmacy's wholesale price, and Tessic takes no revenue share.
OTHER CATEGORIES
Launch in another category
Every plan includes every treatment category, so a brand can add a second one later on the same account.